We are live on ! Find out more
ORIC icon

Oric Pharmaceuticals
ORIC

66 hedge funds and large institutions have $722M invested in Oric Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 66 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

71.95% more ownership

Funds ownership: 0% → 71.95% (+72%)

Holders
66
Holders Change
+66
Holders Change %
–
% of All Funds
1.35%
Holding in Top 10
5
Holding in Top 10 Change
+5
Holding in Top 10 Change %
% of All Funds
0.1%
New
66
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
PS
Peter Svennilson
+$152M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$134M
3
O
OrbiMed
New York
+$93.3M
4
EC
EcoR1 Capital
California
+$84.3M
5
IFA
Invus Financial Advisors
New York
+$32.2M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
M&T Bank
51
M&T Bank
New York
$211K +$200K +6,265 New
JP Morgan Chase
52
JP Morgan Chase
New York
$210K +$198K +6,217 New
VF
53
Virtu Financial
New York
$208K +$197K +6,167 New
Blackstone Inc
54
Blackstone Inc
New York
$186K +$176K +5,500 New
AIG
55
American International Group
New York
$180K +$170K +5,325 New
MIM
56
MetLife Investment Management
New Jersey
$156K +$147K +4,615 New
Deutsche Bank
57
Deutsche Bank
Germany
$150K +$142K +4,445 New
MLICM
58
Metropolitan Life Insurance Company (MetLife)
New York
$107K +$102K +3,187 New
Citigroup
59
Citigroup
New York
$105K +$98.3K +3,080 New
UBS Group
60
UBS Group
Switzerland
$96K +$90.8K +2,844 New
Morgan Stanley
61
Morgan Stanley
New York
$96K +$91.1K +2,853 New
SO
62
STRS Ohio
Ohio
$74K +$70.2K +2,200 New
Legal & General Group
63
Legal & General Group
United Kingdom
$47K +$45.1K +1,412 New
AIP
64
Ameritas Investment Partners
Nebraska
$26K +$24.5K +769 New
Bank of Montreal
65
Bank of Montreal
Ontario, Canada
$17K +$22.2K +695 New
TRCT
66
Tower Research Capital (TRC)
New York
$15K +$14K +438 New
1 2
3

ORIC Hedge Fund Activity: Q2 2020 in Review

66 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Oric Pharmaceuticals (ORIC) for Q2 2020, worth a combined $722M.

Buyers outnumbered sellers: 66 funds opened new ORIC positions and 0 closed out — a net gain of 66 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Peter Svennilson, opening a new position worth an estimated $152M.

  • 66 institutional investors held Oric Pharmaceuticals (ORIC) as of Q2 2020, up from 0 in Q1 2020.
  • Funds reported $722M of Oric Pharmaceuticals stock for Q2 2020.
  • 66 funds opened new Oric Pharmaceuticals positions in Q2 2020 and 0 closed out, a net change of +66 holders.
  • The largest Oric Pharmaceuticals buyer in Q2 2020 was Peter Svennilson, an estimated $152M added.

Based on aggregated 13F filings for Q2 2020.